Karyotype is an independent prognostic factor in adult acute lymphoblastic leukemia (ALL): analysis of cytogenetic data from patients treated on the Medical Research Council (MRC) UKALLXII/Eastern…

By A. Moorman, C. Harrison, G. Buck, S. Richards, L. Secker-Walker, M. Martineau, G. Vance, A. Cherry, R. Higgins, A. Fielding and 8 more. Blood, 2005

760 citations recorded by the source corpus.

Subfields: Hematology, Public Health, Environmental and Occupational Health

View Paper: https://www.semanticscholar.org/paper/044a79792f5ad04faac22758c3c4d96c3780ccea

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Public Health, Environmental and Occupational Health

1. R. Siegel
2. K. Miller
3. A. Jemal

Citations in the corpus

• Cancer treatment and survivorship statistics, 2016 (2016, background): “About 20% to 30% of adult ALL cases and <5% of childhood cases are Philadelphia chromosome-positive and may benefit from the addition of a BCR-ABL TKI to chemotherapy.(66,67) More than 95% of children and from 78% to 92% of adults with ALL attain remission.”